162 related articles for article (PubMed ID: 17258783)
1. Efficient repeated low-dose intravaginal infection with X4 and R5 SHIVs in rhesus macaque: implications for HIV-1 transmission in humans.
Tsai L; Trunova N; Gettie A; Mohri H; Bohm R; Saifuddin M; Cheng-Mayer C
Virology; 2007 May; 362(1):207-16. PubMed ID: 17258783
[TBL] [Abstract][Full Text] [Related]
2. Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.
Tasca S; Tsai L; Trunova N; Gettie A; Saifuddin M; Bohm R; Chakrabarti L; Cheng-Mayer C
Virology; 2007 Oct; 367(1):196-211. PubMed ID: 17574643
[TBL] [Abstract][Full Text] [Related]
3. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
4. Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes.
Chenine AL; Siddappa NB; Kramer VG; Sciaranghella G; Rasmussen RA; Lee SJ; Santosuosso M; Poznansky MC; Velu V; Amara RR; Souder C; Anderson DC; Villinger F; Else JG; Novembre FJ; Strobert E; O'Neil SP; Secor WE; Ruprecht RM
J Infect Dis; 2010 Apr; 201(8):1155-63. PubMed ID: 20214475
[TBL] [Abstract][Full Text] [Related]
5. Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus.
Boadi T; Schneider E; Chung S; Tsai L; Gettie A; Ratterree M; Blanchard J; Neurath AR; Cheng-Mayer C
AIDS; 2005 Oct; 19(15):1587-94. PubMed ID: 16184027
[TBL] [Abstract][Full Text] [Related]
6. Does viral tropism play a role in heterosexual transmission of HIV? Findings in the SIV-rhesus macaque model.
Miller CJ
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1(Suppl 1):S79-82. PubMed ID: 9581889
[TBL] [Abstract][Full Text] [Related]
7. Efficient mucosal transmissibility but limited pathogenicity of R5 SHIV SF162P3N in Chinese-origin rhesus macaques.
Mumbauer A; Gettie A; Blanchard J; Cheng-Mayer C
J Acquir Immune Defic Syndr; 2013 Apr; 62(5):496-504. PubMed ID: 23221980
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N.
Shakirzyanova M; Tsai L; Ren W; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2012 Sep; 86(17):9432-42. PubMed ID: 22740397
[TBL] [Abstract][Full Text] [Related]
9. Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques.
Harouse JM; Tan RC; Gettie A; Dailey P; Marx PA; Luciw PA; Cheng-Mayer C
Virology; 1998 Aug; 248(1):95-107. PubMed ID: 9705259
[TBL] [Abstract][Full Text] [Related]
10. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques.
Trunova N; Tsai L; Tung S; Schneider E; Harouse J; Gettie A; Simon V; Blanchard J; Cheng-Mayer C
Virology; 2006 Aug; 352(1):169-77. PubMed ID: 16730772
[TBL] [Abstract][Full Text] [Related]
11. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3).
Harouse JM; Gettie A; Eshetu T; Tan RC; Bohm R; Blanchard J; Baskin G; Cheng-Mayer C
J Virol; 2001 Feb; 75(4):1990-5. PubMed ID: 11160699
[TBL] [Abstract][Full Text] [Related]
12. Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates.
Otten RA; Adams DR; Kim CN; Jackson E; Pullium JK; Lee K; Grohskopf LA; Monsour M; Butera S; Folks TM
J Infect Dis; 2005 Jan; 191(2):164-73. PubMed ID: 15609225
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
[TBL] [Abstract][Full Text] [Related]
14. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques.
Miller CJ; Marthas M; Greenier J; Lu D; Dailey PJ; Lu Y
J Virol; 1998 Apr; 72(4):3248-58. PubMed ID: 9525652
[TBL] [Abstract][Full Text] [Related]
15. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
[TBL] [Abstract][Full Text] [Related]
16. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques.
Greenier JL; Miller CJ; Lu D; Dailey PJ; Lü FX; Kunstman KJ; Wolinsky SM; Marthas ML
J Virol; 2001 Apr; 75(8):3753-65. PubMed ID: 11264364
[TBL] [Abstract][Full Text] [Related]
17. A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations.
Ma ZM; Abel K; Rourke T; Wang Y; Miller CJ
J Virol; 2004 Dec; 78(24):14048-52. PubMed ID: 15564513
[TBL] [Abstract][Full Text] [Related]
18. Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques.
Lu Y; Brosio P; Lafaile M; Li J; Collman RG; Sodroski J; Miller CJ
J Virol; 1996 May; 70(5):3045-50. PubMed ID: 8627782
[TBL] [Abstract][Full Text] [Related]
19. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.
Berges BK; Akkina SR; Folkvord JM; Connick E; Akkina R
Virology; 2008 Apr; 373(2):342-51. PubMed ID: 18207484
[TBL] [Abstract][Full Text] [Related]
20. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
Kim CN; Adams DR; Bashirian S; Butera S; Folks TM; Otten RA
J Med Primatol; 2006 Aug; 35(4-5):210-6. PubMed ID: 16872284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
